Press release archive - GSK
GSK announces headline results from the FIRST-ENGOT-OV44 phase III trial. Regulatory designation based on promising preliminary clinical data. Designation based on data showing …
Press releases - GSK US
GSK announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the safety of AREXVY and SHINGRIX. GSK confirmed it has reached two …
GSK announces cap of $35 per month on U.S. patient out-of …
GSK today announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all of its asthma and chronic obstructive pulmonary disease (COPD) medicines,* the …
Next stage in GSK’s Zantac defense gets underway today
Jan 22, 2024 · GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused …
GSK plc (GSK) Latest Stock News & Headlines - Yahoo Finance
Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.
GlaxoSmithKline Latest News & Analysis - BBC News
Jan 17, 2022 · What vital life-saving medical device accounts for half of drugmaker GSK's emissions? Can the UK do 100,000 coronavirus tests a day? Find the latest GlaxoSmithKline …
GSK sees strong growth as Haleon split and vaccine drive pays off
Jan 31, 2024 · GSK beat market estimates for fourth-quarter results on Wednesday, and unveiled an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and cancer drugs …
GlaxoSmithKline - BBC News
Jan 17, 2022 · GlaxoSmithKline rejected three offers, saying they "undervalued" its consumer goods business. GSK aims to expand its Stevenage facility to create one of the largest life …
GSK's experimental drug shows promise in reducing severe …
May 21, 2024 · GSK's experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to make …
GlaxoSmithKline News | GSK News - NewsNow
NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine …